Related Experiment Video
Updated: Jul 7, 2025

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
SOD3 regulates FLT1 to affect bone metabolism by promoting osteogenesis and inhibiting adipogenesis through PI3K/AKT
Ke Xu1, Wenchao Fei1, Wenxue Gao2
1Department of Orthopedics, The Fifth People's Hospital of Shanghai, Fudan University, Shanghai, China; Shanghai Clinical Research Center for Aging and Medicine, Shanghai, China; Center of Community-Based Health Research, Fudan University, Shanghai, China.
Abstract:
Osteoporosis is a chronic disease that seriously affects the quality of life and longevity of the elderly, so exploring the mechanism of osteoporosis is crucial for drug development and treatment. Bone marrow mesenchymal stem cells are stem cells with multiple differentiation potentials in bone marrow, and changing their differentiation direction can change bone mass. As an extracellular superoxide dismutase, Superoxide Dismutase 3 (SOD3) has been proved to play an important role in multiple organs, but the detailed mechanism of action in bone metabolism is still unclear. In this study, the results of clinical serum samples ELISA and single cell sequencing chip analysis proved that the expression of SOD3 was positively correlated with bone mass, and SOD3 was mainly expressed in osteoblasts and adipocytes and rarely expressed in osteoblasts in BMSCs. In vitro experiments showed that SOD3 can promote osteogenesis and inhibit adipogenesis. Compared with WT mice, the mice that were knocked out of SOD3 had a significant decrease in bone mineral density and significant changes in related parameters. The results of HE and IHC staining suggested that knocking out SOD3 would lead to fat accumulation in the bone marrow cavity and weakened osteogenesis. Both in vitro and in vivo experiments indicated that SOD3 affects bone metabolism by promoting osteogenesis and inhibiting adipogenesis. The results of transcriptome sequencing and revalidation showed that SOD3 can affect the expression of FLT1. Through in vitro experiments, we proved that FLT1 can also promote osteogenesis and inhibit adipogenesis. In addition, through the repeated experiments, the interaction between the two molecules (SOD3 and FLT1) was verified again. Finally, it was verified by WB that SOD3 regulates FLT1 to affect bone metabolism through PI3K/AKT and MAPK pathways.
Insights
Superoxide Dismutase 3 (SOD3) promotes bone formation and inhibits fat accumulation in bone marrow, offering new therapeutic targets for osteoporosis treatment.
Area of Science:
- Biochemistry
- Cell Biology
- Bone Metabolism
Background:
- Osteoporosis significantly impacts elderly health and longevity, necessitating research into its mechanisms for drug development.
- Bone marrow mesenchymal stem cells (BMSCs) have potential for altering bone mass by directing their differentiation.
- Superoxide Dismutase 3 (SOD3), an extracellular enzyme, plays roles in various organs, but its specific function in bone metabolism remains largely unknown.
Purpose of the Study:
- To investigate the role of Superoxide Dismutase 3 (SOD3) in bone metabolism.
- To elucidate the mechanism by which SOD3 influences osteogenesis and adipogenesis.
- To identify molecular pathways and interactions involved in SOD3-mediated bone regulation.
Main Methods:
- Analysis of clinical serum samples using ELISA and single-cell sequencing.
- In vitro experiments on BMSCs to assess osteogenesis and adipogenesis.
- In vivo studies using SOD3 knockout mice, including bone mineral density measurements, HE staining, and IHC staining.
- Transcriptome sequencing to identify downstream targets of SOD3.
- Western blot (WB) analysis to confirm molecular pathway involvement.
Main Results:
- SOD3 expression positively correlates with bone mass and is primarily found in osteoblasts and adipocytes within BMSCs.
- SOD3 promotes osteogenesis and inhibits adipogenesis in vitro.
- SOD3 knockout mice exhibit reduced bone mineral density, increased bone marrow fat accumulation, and weakened osteogenesis.
- SOD3 influences FLT1 expression, and FLT1 also promotes osteogenesis and inhibits adipogenesis.
- SOD3 regulates FLT1 via the PI3K/AKT and MAPK signaling pathways.
Conclusions:
- SOD3 plays a critical role in maintaining bone metabolism by promoting osteogenesis and inhibiting adipogenesis.
- SOD3 exerts its effects on bone through the regulation of FLT1 expression and activation of the PI3K/AKT and MAPK pathways.
- Targeting SOD3 and its downstream pathways presents a promising therapeutic strategy for managing osteoporosis.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Regulation of Angiogenesis and Blood Supply

